Arterial Vascular Engineering (AVE) completes recruitment for stent trial
This article was originally published in Clinica
Executive Summary
Arterial Vascular Engineering (AVE) has completed recruitment for the SMART multicentre randomised trial which aims to compare restenosis after treatment with its MicroStent and MicroStent-II with the Cordis Palmaz-Schatz stent, the only stent approved for elective use in the US.